…MSS CRC.Methods Preclinical studies used CT26 mouse models (MSS CRC) with oral Akk administration to assess tumor growth effects. T…
All extracted diseases
Showing 1,081–1,140 of 18,081, ordered by supporting articles. Choose a disease to see its evidence.
Articles mentioning diseases
23,712 articles · page 555 of 1976…Background High-grade serous ovarian cancer (HGSOC) is the deadliest gynecological malignancy, with limited…
…ts with either Head and Neck squamous cell carcinoma (HNSCC) or Soft Tissue Sarcoma (STS). Following CIVO intratumoral microdose injections of PBA-…
…red to using only baseline features in ALK+ NSCLC patients with brain metastases receiving TKI therapy. These findings highlight the potential o…
…ad to superior clinical outcomes for IB-T101 CAR-T cells in the ccRCC solid tumor setting.Methods Here we report an in-progress phase…
…unique samples. Compared to HPV+ oropharynx tumors, oral cavity HNSCC had significantly higher proportions of NK cells (p = 0.02), an…
…Malignancies (DREAM) study ( NCT05671887) across three cohorts: bilateral non-small cell lung cancer, pulmonary metastasis only disease, and history of malignancy w…
…d over 2 dose levels to 6 patients (age range 18-66 years) with r/r solid tumors were well-tolerated with no dose limiting toxicities, both alon…
…n. 1 In a vascularized microphysiological system (MPS) model of triple-negative breast cancer, BAL0891 combined with an immune checkpoint inhibitor significa…
…ed.Results From 6/2024 to 3/2025, 31 patients were enrolled (26 non-small cell lung cancer, 4 breast cancer, and 1 small cell lung cancer). At the initial…
…y targeting epidermal growth factor receptor (EGFR) in advanced solid tumors with human leukocyte antigen (HLA) loss of heterozygosity (LOH)…
…ty in treatment-refractory advanced cutaneous melanoma (CM) and synovial sarcoma (SS); there are opportunities to further improve outcomes in th…